Current and historical daily PE Ratio for Valeo Pharma Inc (
) from 2019 to Sep 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Valeo Pharma stock (TSX:VPH) PE ratio as of Sep 20 2024 is 0.
More Details
Valeo Pharma Inc (TSX:VPH) PE Ratio (TTM) Chart
Valeo Pharma Inc (TSX:VPH) PE Ratio (TTM) Historical Data
View and export this data going back to 2019. Start your Free Trial
Total 1243
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Valeo Pharma PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-09-20 | At Loss | 2024-07-17 | At Loss |
| 2024-09-19 | At Loss | 2024-07-16 | At Loss |
| 2024-09-18 | At Loss | 2024-07-15 | At Loss |
| 2024-09-17 | At Loss | 2024-07-12 | At Loss |
| 2024-09-16 | At Loss | 2024-07-11 | At Loss |
| 2024-09-13 | At Loss | 2024-07-10 | At Loss |
| 2024-09-12 | At Loss | 2024-07-09 | At Loss |
| 2024-09-11 | At Loss | 2024-07-08 | At Loss |
| 2024-09-10 | At Loss | 2024-07-05 | At Loss |
| 2024-09-09 | At Loss | 2024-07-04 | At Loss |
| 2024-09-06 | At Loss | 2024-07-03 | At Loss |
| 2024-09-05 | At Loss | 2024-07-02 | At Loss |
| 2024-09-04 | At Loss | 2024-06-28 | At Loss |
| 2024-09-03 | At Loss | 2024-06-27 | At Loss |
| 2024-08-30 | At Loss | 2024-06-26 | At Loss |
| 2024-08-29 | At Loss | 2024-06-25 | At Loss |
| 2024-08-28 | At Loss | 2024-06-24 | At Loss |
| 2024-08-27 | At Loss | 2024-06-21 | At Loss |
| 2024-08-26 | At Loss | 2024-06-20 | At Loss |
| 2024-08-23 | At Loss | 2024-06-19 | At Loss |
| 2024-08-22 | At Loss | 2024-06-18 | At Loss |
| 2024-08-21 | At Loss | 2024-06-17 | At Loss |
| 2024-08-20 | At Loss | 2024-06-14 | At Loss |
| 2024-08-19 | At Loss | 2024-06-13 | At Loss |
| 2024-08-16 | At Loss | 2024-06-12 | At Loss |
| 2024-08-15 | At Loss | 2024-06-11 | At Loss |
| 2024-08-14 | At Loss | 2024-06-10 | At Loss |
| 2024-08-13 | At Loss | 2024-06-07 | At Loss |
| 2024-08-12 | At Loss | 2024-06-06 | At Loss |
| 2024-08-09 | At Loss | 2024-06-05 | At Loss |
| 2024-08-08 | At Loss | 2024-06-04 | At Loss |
| 2024-08-07 | At Loss | 2024-06-03 | At Loss |
| 2024-08-06 | At Loss | 2024-05-31 | At Loss |
| 2024-08-02 | At Loss | 2024-05-30 | At Loss |
| 2024-08-01 | At Loss | 2024-05-29 | At Loss |
| 2024-07-31 | At Loss | 2024-05-28 | At Loss |
| 2024-07-30 | At Loss | 2024-05-27 | At Loss |
| 2024-07-29 | At Loss | 2024-05-24 | At Loss |
| 2024-07-26 | At Loss | 2024-05-23 | At Loss |
| 2024-07-25 | At Loss | 2024-05-22 | At Loss |
| 2024-07-24 | At Loss | 2024-05-21 | At Loss |
| 2024-07-23 | At Loss | 2024-05-17 | At Loss |
| 2024-07-22 | At Loss | 2024-05-16 | At Loss |
| 2024-07-19 | At Loss | 2024-05-15 | At Loss |
| 2024-07-18 | At Loss | 2024-05-14 | At Loss |
Valeo Pharma Inc (TSX:VPH) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Valeo Pharma Inc
NAICS : 325412
SIC : 3741
ISIN : CA91915B1085
Share Class Description:
TSX:VPH: Ordinary SharesCompare
Compare
Traded in other countries / regions
VPH.CanadaVP2.GermanyVPHIF.USA IPO Date
2019-02-20Description
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers